Apr. 10 at 4:59 PM
$GOVX $GOVX looks pretty sold out after that financing. I presume the company is needing the capital to continue with their clinical trials. Expecting some catalyst before the end of the quarter, but the last time I traded this it ran up over 40% in one week. Just got the new research report from Noble. They cut the target price to
$10 because of factoring in the increase in shares outstanding, but I would be happy with
$3.00. Check that chart out---looking for a base building for a few days before getting in. JMO.
